Literature DB >> 25048284

Vibrational spectroscopic (FTIR and FT-Raman), first-order hyperpolarizablity, HOMO, LUMO, NBO, Mulliken charge analyses of 2-ethylimidazole based on Hartree-Fock and DFT calculations.

M Arivazhagan1, S Manivel2, S Jeyavijayan3, R Meenakshi4.   

Abstract

The FTIR and FT-Raman spectra of 2-ethylimidazole (2EIDZ) have been recorded in the region 4000-400 cm(-1) and 3500-50 cm(-1), respectively. Utilizing the observed FTIR and FT-Raman data, a complete vibrational assignment and analysis of the fundamental modes of the compound were carried out. The optimized molecular geometry, harmonic vibrational frequencies, infrared intensities and Raman scattering activities, were calculated by ab initio Hartree-Fock (HF) and density functional theory (DFT/B3LYP) methods with 6-311++G(d,p) basis set. The difference between the observed and scaled wavenumber values of most of the fundamentals is very small. A detailed interpretation of the infrared and Raman spectra of 2EIDZ is also reported based on total energy distribution (TED). The values of the total dipole moment (μ) and the first-order hyperpolarizability (β) of the compound were computed. Stability of the molecule arising from hyperconjugative interactions, charge delocalization have been analyzed using natural bond orbital (NBO) analysis. Besides, HOMO and LUMO analysis, Mulliken's charge analysis and several thermodynamic properties have been calculated.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-Ethylimidazole; Ab initio; DFT calculations; FT-Raman; FTIR

Mesh:

Substances:

Year:  2014        PMID: 25048284     DOI: 10.1016/j.saa.2014.06.108

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Predicting the degradation potential of Acid blue 113 by different oxidants using quantum chemical analysis.

Authors:  Anam Asghar; Mustapha Mohammed Bello; Abdul Aziz Abdul Raman; Wan Mohd Ashri Wan Daud; Anantharaj Ramalingam; Sharifuddin Bin Md Zain
Journal:  Heliyon       Date:  2019-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.